The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarwyn Value 16 Regulatory News (MVIR)

Share Price Information for Marwyn Value 16 (MVIR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 233.00
Bid: 200.00
Ask: 266.00
Change: 0.00 (0.00%)
Spread: 66.00 (33.00%)
Open: 233.00
High: 233.00
Low: 233.00
Prev. Close: 233.00
MVIR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of cash offer for BCA Marketplace plc

6 Nov 2019 12:01

RNS Number : 5064S
Marwyn Value Investors Limited
06 November 2019
 

LEI: 213800L5751QTTVEA7746 November 2019

 

MARWYN VALUE INVESTORS LIMITED (the "Company" or "MVIL")

COMPLETION OF CASH OFFER FOR BCA MARKETPLACE PLC ("BCA")

 

 

Further to the Company's announcement on 20 June 2019, the Directors welcome the announcement by BCA today, confirming that the scheme for the £1.9 billion all-cash acquisition by TDR Capital LLP is now effective.

 

Completion of the acquisition will generate proceeds of approximately £60.2 million attributable to the Company's ordinary shareholders and approximately £5.3 million attributable to the Company's realisation shareholders. Receipt of the sales proceeds is expected by 20 November 2019.

 

Completion of the all-cash offer represents a 1.6x cash multiple and 14.4% IRR on the Marwyn Funds'1 investment in BCA.

 

James Corsellis, Managing Partner of Marwyn Investment Management LLP, said: "We would like to thank Avril and her entire team at BCA for their hard work and commitment in transforming BCA over the last 4 years and delivering such a successful outcome for all shareholders. We are delighted to have worked with Avril and the team from the launch of the initial platform, Haversham Holdings, and look forward to the continued success of the business under TDR's ownership."

 

Robert Ware, MVIL Chairman, commented: "The sale of BCA to TDR delivers a successful outcome for MVIL and supports the Manager's track record of backing exceptional management teams to execute investment strategies that can generate shareholder value. The Manager continues to assess opportunities to reinvest the resulting capital now available to the Marwyn Funds."

 

Use of Proceeds

Under the Company's Ordinary Share Distribution Policy, as defined in the Company's announcement on 14 August 2018, when the Marwyn Funds dispose of an asset for a Net Capital Gain and the Company has not already returned to ordinary shareholders an aggregate amount in excess of 50 per cent. of that gain and any previous such gains, such an amount will be distributed to ordinary shareholders. Since the sale of Entertainment One in 2015, the Company has returned over £24 million to ordinary shareholders through a combination of dividends and share purchases under the Company's share buyback scheme. As such, no special dividend is required following this disposal.

 

Marwyn Asset Management Limited, as manager to the Marwyn Funds (the "Manager"), intends to use the proceeds attributable to the Company's ordinary shareholders to support follow on investments in the current portfolio and to support the launch of new management teams and acquisition companies.

 

Under the terms of the Company's realisation class, subject to any cash held back for reasonable working capital purposes, any cash generated from the realisation of assets is to be distributed to realisation shareholders (net of any relevant incentive allocation payments). The Company will make a further announcement in due course to inform realisation shareholders of the process by which such capital shall be returned to them in connection with the disposal of the Company's shares in BCA.

 

1 The Marwyn Funds comprise the Company, Marwyn Value Investors LP, Marwyn Value Investors II LP and MVI II Co-Invest LP. The total proceeds expected to be received by the Marwyn Funds as a result of the offer, including amounts attributable to external third-party investors, is £85.9 million.

 

Company enquiries:

Louisa Bonney / Scott Danks

Axio Capital Solutions Limited

Telephone: 01534 761240

 

Gillian Martin

Liberum Capital Limited

Telephone: 020 3100 2200

 

PR enquiries:

Alex Child-Villiers / Will Barker

Temple Bar Advisory Limited

Telephone: 020 7975 1415

 

Notes to editors:

Marwyn Value Investors Limited is a closed-ended investment company listed on the London Stock Exchange Specialist Fund Segment - a fully regulated market for professional, institutional and sophisticated investors. Current investments through its underlying funds include Zegona Communications plc, Le Chameau Group plc, Safe Harbour Holdings plc and Wilmcote Holdings plc.

For further information see www.marwynvalue.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUGGUUGUPBGPQ
Date   Source Headline
26th Nov 20218:51 amRNSNet Asset Value
19th Nov 202112:37 pmRNSNet Asset Value
12th Nov 202112:52 pmRNSNet Asset Value
5th Nov 20212:26 pmRNSNet Asset Value
5th Nov 202111:01 amRNSPartial Cash Redemption of Realisation Shares
27th Oct 20211:10 pmRNSNet Asset Value
22nd Oct 20219:01 amRNSNet Asset Value
15th Oct 20217:00 amRNSDistribution to Realisation Shareholders
13th Oct 20219:20 amRNSNet Asset Value
8th Oct 20217:00 amRNSCompletion of Zegona Tender Offer
1st Oct 202112:09 pmRNSNet Asset Value
24th Sep 202112:03 pmRNSNet Asset Value
13th Sep 20219:20 amRNSNet Asset Value
7th Sep 20215:06 pmRNSInvestment Update
3rd Sep 202111:38 amRNSNet Asset Value
25th Aug 20213:02 pmRNSNet Asset Value
20th Aug 20219:20 amRNSNet Asset Value
13th Aug 202112:40 pmRNSNet Asset Value
6th Aug 20211:04 pmRNSNet Asset Value
30th Jul 202110:59 amRNSNet Asset Value
22nd Jul 202110:38 amRNSNet Asset Value
14th Jul 202110:27 amRNSNet Asset Value
2nd Jul 20219:26 amRNSNet Asset Value
25th Jun 20212:21 pmRNSNet Asset Value
11th Jun 20211:30 pmRNSNet Asset Value
4th Jun 202111:19 amRNSNet Asset Value
28th May 20218:41 amRNSNet Asset Value
21st May 20212:16 pmRNSNet Asset Value
14th May 202111:14 amRNSNet Asset Value
7th May 20211:14 pmRNSNet Asset Value
30th Apr 20213:05 pmRNSNet Asset Value
23rd Apr 202111:31 amRNSNet Asset Value
15th Apr 20219:48 amRNSNet Asset Value
1st Apr 20213:28 pmRNSNet Asset Value
26th Mar 20218:47 amRNSNet Asset Value
19th Mar 20212:43 pmRNSNet Asset Value
11th Mar 20218:59 amRNSNet Asset Value
4th Mar 20214:53 pmRNSNet Asset Value
25th Feb 20215:25 pmRNSNet Asset Value
19th Feb 20219:16 amRNSNet Asset Value
11th Feb 20214:08 pmRNSNet Asset Value
5th Feb 20219:33 amRNSNet Asset Value
28th Jan 20214:05 pmRNSNet Asset Value
22nd Jan 202110:29 amRNSNet Asset Value
15th Jan 202112:49 pmRNSNet Asset Value
15th Jan 202111:22 amRNSResult of EGM
5th Jan 20212:04 pmRNSNet Asset Value
23rd Dec 20205:41 pmRNSNet Asset Value
16th Dec 20203:34 pmRNSDistribution Policy Implementation & Notice of EGM
10th Dec 20204:23 pmRNSNet Asset Value

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.